Show
Sort by
-
- Journal Article
- A1
- open access
Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?
-
- Journal Article
- A1
- open access
Enhanced TCR footprint by a novel glycolipid increases NKT-dependent tumor protection
-
Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis
-
Haplotype 4 of the multiple sclerosis-associated interleukin-7 receptor alpha gene influences the frequency of recent thymic emigrants
-
Invariant natural killer T cells are natural regulators of murine spondylarthritis
-
Compromised CD4+ CD25high regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level